Legend Biotech Corporation (LEGN)
NASDAQ: LEGN · Real-Time Price · USD
20.27
-0.38 (-1.84%)
Aug 13, 2026, 4:00 PM EDT - Market closed
Legend Biotech Revenue
Legend Biotech had revenue of $387.50M in the quarter ending June 30, 2026, with 51.90% growth. This brings the company's revenue in the last twelve months to $1.27B, up 59.54% year-over-year. In the year 2025, Legend Biotech had annual revenue of $1.03B with 64.02% growth.
Revenue (ttm)
$1.27B
Revenue Growth
+59.54%
P/S Ratio
3.08
Revenue / Employee
$428,803
Employees
2,965
Market Cap
3.92B
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2025 | 1.03B | 401.60M | 64.02% |
| Dec 31, 2024 | 627.30M | 342.20M | 120.03% |
| Dec 31, 2023 | 285.10M | 168.10M | 143.66% |
| Dec 31, 2022 | 117.01M | 48.18M | 70.00% |
| Dec 31, 2021 | 68.83M | -6.17M | -8.23% |
| Dec 31, 2020 | 75.00M | 15.02M | 25.04% |
| Dec 31, 2019 | 59.98M | 10.85M | 22.08% |
| Dec 31, 2018 | 49.13M | 25.54M | 108.24% |
| Dec 31, 2017 | 23.59M | - | - |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Related Stocks
| Company Name | Revenue |
|---|---|
| Telix Pharmaceuticals | 803.79M |
| IDEAYA Biosciences | 234.13M |
| Arcus Biosciences | 117.00M |
| Tango Therapeutics | 53.81M |
| Relay Therapeutics | 10.35M |
| Denali Therapeutics | 3.60M |
LEGN News
- 2 days ago - Legend Biotech Earnings Call Transcript: Q2 2026 - Transcripts
- 2 days ago - Legend Biotech Earnings release: Q2 2026 - Filings
- 2 days ago - Legend Biotech Slides: Q2 2026 - Filings
- 2 days ago - Legend Biotech reports Q2 EPS 16c vs. 3c last year - TheFly
- 17 days ago - Legend Biotech falls -15.1% - TheFly
- 17 days ago - Legend Biotech falls -12.5% - TheFly
- 17 days ago - Legend Biotech price target lowered to $59 from $63 at RBC Capital - TheFly
- 17 days ago - Legend Biotech CEO Ying Huang steps down, Alan Bash named interim CEO - TheFly